Editas Medicine (EDIT) Tops Q2 EPS by 12c
Tweet
Share
E-mail
Get Alerts EDIT Hot Sheet
Join SI Premium – FREE
Editas Medicine (NASDAQ: EDIT) reported Q2 EPS of ($0.15), $0.12 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $11.89 million.
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paysign, Inc. (PAYS) Tops Q2 EPS by 5c ; Offers Guidance
- Granite Point Mortgage Trust Inc. (GPMT) Misses Q2 EPS by 43c
- CrossAmerica Partners (CAPL) Tops Q2 EPS by 31c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
